Reply to Clarification- Financial results

.... -. Narayana Health Date of submission: July 01, 2026 The Secretary Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Mumbai – 400 051 Scrip Code- NH Dear Sir/Madam, Subject: Clarification in response to NSE email dated June 29, 2026 regarding Financial Results submitted on May 22, 2026. With reference to your email dated June 29, 2026 regarding the Financial Results submitted by the Company on May 22, 2026, we wish to submit the following clarifications: 1. Machine Readable Form / Legible Copy of Financial Results We wish to inform you that the Audited Financial Results (Standalone and Consolidated) for the quarter and Financial Year ended March 31, 2026 together with Auditors’ Report thereon were submitted to the Exchange on May 22, 2026, within the prescribed timelines. Pursuant to your email, the Company is re-submitting a legible and machine-readable copy of the said financial results through this. We further confirm that there is no change in the contents of the financial results originally submitted by the Company on May 22, 2026. The present submission is only to provide a legible/machine-readable copy as requested by the Exchange. 2. Financial Results submitted in XBRL with discrepancies- Reserves excluding revaluation reserve not mentioned in XBRL We have verified the XBRL filing (standalone) and the revised XBRL has been submitted to the Exchange. We trust the above clarifications adequately address the observations raised by the Exchange. We request you to kindly take the above on record. Thanking you, Yours faithfully For Narayana Hrudayalaya Limited Sridhar S. Group Company Secretary, Legal & Compliance Officer Encl.: as above Narayana Hrudayalaya Limited Appointments CIN: L85110KA2000PLC027497 186-0208-0208 Registe red Office: 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099 Corporate Office: 261/A, 2nd Floor, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099 Tel +91 80 7122 2636 I Fax +91 80 2783 2648 I Email: info@narayanahealth.org I www.narayanahealth.org .--. N~ arayana Health Date of submission: May 22, 2026 To, To, The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Sandra Kurla Complex Phiroze Jeejeebhoy Towers, Mumbai - 400 051 Dalal Street, Mumbai - 400 001 Scrip Code - 539551 (EQ), 975516 & 976418 Scrip Code-NH Dear Sir/Madam, Sub: Outcome of the Board Meeting held on May 22, 2026 Pursuant to Regulation 30 read with Regulations 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 ("SEBI Listing Regulations"), this is to inform you that the Board of Directors of the Company at its meeting held today, i.e. May 22, 2026 (Friday) inter a/ia, has approved the following: 1. Audited Financial Results (Standalone and Consolidated) for the quarter and Financial Year ended March 31, 2026 together with Auditors' Report thereon, pursuant to Regulation 33 and Regulation 52 of the SEBI Listing Regulations. A copy of the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and Financial Year ended March 31, 2026 together with Auditors' Report thereon is enclosed as Annexure -A for your information. 2. We hereby declare that the Statutory Auditors of the Company, M/s. Deloitte Haskins & Sells LLP, have issued an Audit Report with unmodified opinion on Audited Financial Results (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026. 3. The 26th Annual General Meeting (AGM) of the Company will be held on Friday, August 14, 2026 by means of Video Conferencing (VC)/Other Audio-Visual Means (OAVM). 4. The Board of Directors has recommended a final dividend of Rs. 4.50/- (Rupees Four and Fifty Paisa Only) per share, for the year ended March 31, 2026, for approval of shareholders of the Company at the ensuing Annual General Meeting. The payment of said dividend will be made within the statutorily prescribed time of 30 days from the date of approval by the Shareholders at the ensuing AGM. 5. The Company has fixed Friday, July 17, 2026 as the record date to ascertain the shareholders who will be entitled to receive a dividend. 6. The Board has resolved to seek enabling approval from the shareholders by way of Special Resolution for issuing Debt Securities (secured or unsecured) including Non-Convertible Debentures (NCDs) for an amount not exceeding Rs.1,500 Crores in a financial year, in one or more series/ tranches, denominated in Indian Rupees or in any foreign currency on a private placement basis. Narayana Hrudayalaya Limited Appointments CIN: L85110KA2000PLC027497 186-0208-0208 Registered Office: 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099 Corporate Office: 261/A, 2nd Floor, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099 Tel +91 80 7122 2636 I Fax +91 80 2783 2648 I Email: info@narayanahealth.org I www.narayanahealth.org .--. N~ arayana Health 7. Re-appointment of Ms. Terri Smith Bresenham (DIN: 09111500) as an Independent Director of the Company w.e.f. August 5, 2026, not be liable to retire by rotation, for a second term of five consecutive years commencing from August 5, 2026 up to August 4, 2031, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting and such other approvals as may be required under applicable law. Ms. Terri Smith Bresenham satisfies the criteria of independence prescribed under the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and is not debarred from being appointed as Director of the Company by virtue of any order of Ministry of Corporate Affairs (MCA), Securities Exchange Board of India (SEBI) or any other such statutory authority. Further, the details as required under SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/l/3762/2026 dated January 30, 2026 is enclosed as Annexure - B. The meeting of the Board of Directors commenced at 03:30 P.M. 1ST and ended at 07:00 P.M. 1ST. This is for your information and records. Thanking you Yours faithfully For Narayana Hrudayalaya Limited SESH IAH Digitally ,igo,d SRIDHA bySESHIAH SRIDHAR R Date: 2026.05.22 21:33:46+os•30• Sridhar S. Group Company Secretary, Legal & Compliance Officer Encl.: as above Narayana Hrudayalaya Limited Appointments CIN: L85110KA2000PLC027497 186-0208-0208 Registered Office: 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099 Corporate Office: 261/A, 2nd Floor, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099 Tel +91 80 7122 2636 I Fax +91 80 2783 2648 I Email: info@narayanahealth.org I www.narayanahealth.org Deloitte Chartered Accountants Prestige Trade Tower, Level 19 46, Palace Road, High Grounds Haskins & Sells LLP Bengaluru - 560 001 Karnataka, India Tel: +91 80 6188 6000 Fax: +91 80 6188 6011 INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL STANDALONE FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS TO THE BOARD OF DIRECTORS OF NARAYANA HRUDAYALAYA LIMITED Opinion and Conclusion We have (a) audited the Standalone Financial Results for the year ended March 31, 2026 and (b) reviewed the Standalone Financial Results for the quarter ended March 31, 2026 (refer 'Other Matters' section below), which were subject to limited review by us, both included in the accompanying "Statement of Standalone Financial Results for the Quarter and Year Ended March 31, 2026" of Narayana Hrudayalaya Limited (the "Company"), (the "Statement"), being submitted by the Company pursuant to the requirements of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "LODR Regulations"). (a) Opinion on Annual Standalone Financial Results In our opinion and to the best of our information and according to the explanations [Showing first 8,000 characters — download PDF for full document]